John M. Dunham, Chief Accounting Officer of Edgewell Personal Care Co (NYSE:EPC), filed a Form 4 on November 17, 2026, disclosing the vesting of restricted stock equivalents, a tax-withholding share disposal, and a new restricted stock equivalent award with transactions dated November 13 through November 16, 2026.

Key Highlights

  • RSE vesting: 1,196 restricted stock equivalents granted November 14, 2025, vested and converted into shares of Edgewell common stock on November 16, 2026, at a derivative security price of $0.
  • Shares acquired: 1,196 shares of common stock were acquired (transaction code M) on November 16, 2026, at a price of $0, bringing directly held shares to 1,529.
  • Tax withholding disposal: 321 shares were disposed of on November 16, 2026, at $28.38 per share, withheld as payment of a tax liability on vesting of performance stock equivalents, reducing direct holdings to 1,208 shares.
  • New RSE grant: 2,750 restricted stock equivalents were awarded on November 13, 2026, at a price of $0, with vesting in equal one-third installments on November 13, 2027, November 13, 2028, and November 13, 2029, subject to continued employment or qualifying events.
  • Post-transaction derivative holdings: Following the transactions, Dunham directly holds 2,750 of the new RSEs and 2,390 of the November 14, 2025 RSEs, according to the filing.
  • Ownership form: All reported securities are held directly by the reporting person.

Dunham's November 2026 Equity Transactions at Edgewell Personal Care

According to the Form 4 filed with the SEC on November 17, 2026, John M. Dunham, identified as Chief Accounting Officer of Edgewell Personal Care Co, reported two categories of equity activity. The first involved the settlement of previously granted restricted stock equivalents. RSEs originally granted on November 14, 2025, vested on November 16, 2026, converting 1,196 units into shares of EPC common stock. As a result of this vesting, Dunham's direct common stock holdings rose to 1,529 shares before the tax-related disposal.

The filing also reports that 321 shares were withheld on November 16, 2026, at a price of $28.38 per share as payment of a tax liability on the vesting of performance stock equivalents. Following that disposal, Dunham's direct common stock holdings stood at 1,208 shares, the filing states. Separately, the filing records a new award of 2,750 restricted stock equivalents dated November 13, 2026. The filing explains that one-third of those RSEs will vest and convert into shares of Edgewell common stock on each of November 13, 2027, November 13, 2028, and November 13, 2029, if Dunham is employed on those dates, or all or a portion may vest upon death, disability, change in control, or certain termination events, as stated in the filing's explanation of responses.

After all reported transactions, the filing shows Dunham directly holds 1,208 shares of common stock, 2,750 RSEs from the November 13, 2026 grant, and 2,390 RSEs remaining from the November 14, 2025 grant.

What Was Disclosed

Edgewell Personal Care Co's Chief Accounting Officer John M. Dunham disclosed the vesting of 1,196 RSEs, disposal of 321 shares at $28.38 for tax purposes, and receipt of a new 2,750-unit RSE award, all between November 13 and November 16, 2026.